The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in cervical cancer: Data from phase 1 and phase 2 studies.
 
Julius Strauss
Research Funding - Bavarian Nordic (Inst); EMD Serono (Inst); ImmunityBio (Inst); PDS Biotechnology (Inst); Precigen (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on NIH pending patent (Inst)
 
Fadi S. Braiteh
Honoraria - Amgen; ARIAD; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Daiichi Sankyo/Lilly; Genentech/Roche; Gilead Sciences; Guardant Health; Immunomedics; Incyte; Ipsen; Lexicon; Lilly; Puma Biotechnology; Regeneron; Sanofi/Aventis; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Coherus Biosciences; Daiichi Sankyo/Lilly; Deciphera; Eisai; Exelixis; Genentech/Roche; Guardant Health; Immunomedics; Incyte; Ipsen; Lilly; Merck; Merck; Merck; Pfizer; Regeneron; Sanofi; Taiho Oncology; Taiho Oncology; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merck; Merrimack; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bayer/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; HERON; Incyte; Insys Therapeutics; Ipsen; Lexicon; Merrimack; Novartis; Pfizer; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical; Tesaro
 
Emiliano Calvo
Employment - HM Hospitales; START
Leadership - START
Stock and Other Ownership Interests - Oncoart Associated; START
Honoraria - HM Hospitales
Consulting or Advisory Role - Adcendo; Alkermes; Amcure; Amunix; Anaveon; Bristol-Myers Squibb; Janssen-Cilag; Nanobiotix; PharmaMar; PsiOxus Therapeutics; Roche/Genentech; Seagen; Servier; TargImmune Therapeutics
Research Funding - Achilles Therapeutics (Inst); BeiGene; START
Other Relationship - Investigational Therapeutics in Oncological Sciences
 
Maria De Miguel
Honoraria - Janssen; MSD Oncology; Roche
(OPTIONAL) Uncompensated Relationships - Abbvie; Array BioPharma; Eisai; Genmab; Janssen; Lilly; MSD; Novartis; PharmaMar; Roche; Sanofi
 
Andres Cervantes
Consulting or Advisory Role - Amgen (Inst); BeiGene (Inst); BMS (Inst); Merck Serono (Inst)
Research Funding - Abbvie (Inst); Activate Therapeutics (Inst); Alkermes (Inst); Amgen (Inst); Astellas Pharma (Inst); BeiGene (Inst); Bioncotech (Inst); Boehringer Ingelheim (Inst); Debiopharm Group (Inst); F. Hoffmann LaRoche (Inst); FibroGen (Inst); Genmab (Inst); Janssen Research & Development (Inst); MedImmune (Inst); Menarini (Inst); Novartis (Inst); Puma Biotechnology (Inst); Symphogen (Inst); Taiho Pharmaceutical (Inst); Transgene (Inst); WntResearch (Inst)
 
William Jeffery Edenfield
Consulting or Advisory Role - Chimerix
 
Tianhong Li
Consulting or Advisory Role - Archer; Eisai; Foundation Medicine
Research Funding - Eureka Therapeutics (Inst); Hengrui Therapeutics (Inst); Merck (Inst); OncoImmune/OncoC4 (Inst); Pfizer (Inst); RasCal (Inst); Tempus (Inst)
 
Marika Anna Rasschaert
No Relationships to Disclose
 
Tjoung-Won Park-Simon
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Genomic Health International; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Hexal; Lilly; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Pfizer; Roche; Tesaro
 
Federico Longo
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Ferrer; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; MSD; Roche; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Ferrer; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Ipsen; Lilly; Merck Serono; Mirati Therapeutics; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Servier; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Alexander I. Spira
Stock and Other Ownership Interests - Lilly
Honoraria - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Janssen Oncology; Merck; Novartis; Takeda
Consulting or Advisory Role - Amgen; Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Gritstone Bio; incyte; Jazz Pharmaceuticals; Merck (Inst); Mirati Therapeutics; Novartis
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); ADC Therapeutics (Inst); Amgen (Inst); Arch Therapeutics (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Gritstone Bio (Inst); Ignyta (Inst); Incyte (Inst); Janssen Oncology (Inst); LAM Therapeutics; LAM Therapeutics (Inst); Loxo (Inst); Loxo (Inst); Macrogenics (Inst); MedImmune (Inst); Mirati Therapeutics (Inst); Newlink Genetics (Inst); Novartis (Inst); Plexxikon (Inst); Roche (Inst); Rubius Therapeutics (Inst); Takeda (Inst); Trovagene (Inst)
 
Genevieve Jehl
Employment - Merck KGaA
 
Isabelle Dussault
Employment - EMD Serono
 
Laureen S. Ojalvo
Employment - EMD Serono
Patents, Royalties, Other Intellectual Property - EMD Serono
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst)
 
Suzanne Wendy Allan
No Relationships to Disclose